How is low voltage electron microscopy revolutionising the electron microscopy landscape – making the practice more accessible in pharma labs?

Massive sequencing, or next-generation sequencing, has opened the door to the fascinating world of genetics, and the secret on how to use this powerful tool most effectively hinges on the starting point: the sample

What is super-resolution microscopy and how is it accelerating progress across the imaging sector?

As novel biologics reshape the therapeutic landscape, more advanced analytics are essential. Single-particle technologies can help fill this gap, delivering faster, clearer insights and supporting the next generation of advanced therapies

1-3 July 2025, Manchester, UK

Bispecific antibodies are revolutionising biotherapeutic development, offering enhanced efficacy by targeting two antigens simultaneously. However, their structural complexity presents significant purification challenges. Advances in mixed-mode chromatography and scalable purification strategies are optimising production, improving yield, purity and cost efficiency, while ensuring a seamless transition from research to commercial manufacturing

Ruizhi Wang at Abselion talks to IPT about how non-optical sensor technologies are unlocking critical process data at the bench and bioreactor

One of the biggest events of its kind in Europe, mmc2025 (incorporating EMAG 2025) will bring you the very best in microscopy, imaging and cytometry from across the globe.

Society recognises outstanding achievements in microscopy, imaging and flow cytometry

Recent advancements in MALDI mass spectrometry imaging are transforming disease understanding and treatment. This innovation promises rapid diagnostics and personalised medicine, with reliable imaging within five years

Thermo Fisher Scientific discusses the role of process analytical technology in addressing the process challenges concerning fermentation and cell culture in biotechnology and enhancing quality and speed production

IPT talks to Yama Abassi at Agilent about immunology and cell analysis and how these will develop in the future